TITLE

Hormesis in Regulatory Risk Assessment - Science and Science Policy

AUTHOR(S)
Gray, George
PUB. DATE
April 2011
SOURCE
Dose-Response;2011, Vol. 9 Issue 2, p158
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
This brief commentary will argue that whether hormesis is considered in regulatory risk assessment is a matter less of science than of science policy. I will first discuss the distinction between science and science policy and their roles in regulatory risk assessment. Then I will focus on factors that influence science policy, especially as it relates to the conduct of risk assessments to inform regulatory decisions, with a focus on the U.S. Environmental Protection Agency (EPA). The key questions will then be how does hormesis interact with current concepts of science and science policy for risk assessment? Finally, I look ahead to factors that may increase, or decrease, the likelihood of hormesis being incorporated into regulatory risk assessment.
ACCESSION #
67699263

 

Related Articles

  • An examination of the Environmental Protection Agency risk assessment principles and practices: a brief commentary on section 4.1.3 of the EPA March 2004 Staff Paper. Mundt, K. A. // Human & Experimental Toxicology;Jan2006, Vol. 25 Issue 1, p19 

    The US Environmental Protection Agency (EPA) recently issued a Staff Paper that articulates current risk assessment practices. In section 4.1.3, EPA states, "...effects that appear to be adaptive, non-adverse, or beneficial may not be mentioned." This statement may be perceived as precluding...

  • Science-policy in environmental and health risk assessment: if we cannot do without, can we do better? Ricci, P. F.; Cox, Jr., L. A.; MacDonald, T. R. // Human & Experimental Toxicology;Jan2006, Vol. 25 Issue 1, p29 

    How can empirical evidence of adverse effects from exposure to noxious agents, which is often incomplete and uncertain, be used most appropriately to protect human health? We examine several important questions on the best uses of empirical evidence in regulatory risk management decision-making...

  • Report recommends holistic approach to regulating. Harrigan, Kate // Pollution Engineering;Jul99, Vol. 31 Issue 7, p15 

    Focuses on the Integrated Environmental Decision-Making in the Twenty First Century, a draft report released by the Science Advisory Board of the Environmental Protection Agency (EPA) in the United States. Comments on laws controlling pollution; Need for environmental risk assessment;...

  • Notice of Availability of the External Review Draft of Framework for Human Health Risk Assessment To Inform Decision Making. Paulson, Glenn // Federal Register (National Archives & Records Service, Office of;7/30/2012, Vol. 77 Issue 146, p44613 

    The article focuses on the availability of the external review draft of the U.S. Environmental Protection Agency's (EPA) "A Framework for Human Health Risk Assessment to Inform Decision Making." The release of the draft document intends to seek for public comment before the external peer review...

  • Science policy considerations for responsible nanotechnology decisions. Morris, Jef; Willis, Jim; De Martinis, Domenico; Hansen, Bjorn; Laursen, Henrik; Sintes, Juan Riego; Kearns, Peter; Gonzalez, Mar // Nature Nanotechnology;Feb2011, Vol. 6 Issue 2, p73 

    The authors discuss the science policy factors considered by government officials in making decisions regarding the use of nanotechnology. The European Union (EU) issued its first action plan on nanosciences and nanotechnologies in 2005, which was reviewed in 2009, while the U.S. Environmental...

  • Comment on “Legal implications of hormesis” by Frank B. Cross. Wagner, W.E. // Human & Experimental Toxicology;Mar2001, Vol. 20 Issue 3, p156 

    Comments on the study of Frank B. Cross on the legal implications of hormesis. Views on how hormesis might affect regulatory practices; Critical assumptions about hormesis; Impact of hormesis on risk assessment.

  • Hormesis and ethics: introduction. Calabrese, E. J. // Human & Experimental Toxicology;Aug2008, Vol. 27 Issue 8, p601 

    The author focuses on hormesis and explains how hormesis can be related to some ethical issues. He explains that hormesis as a biological concept about the dose response. He claims that ethical issues related to hormesis come in as experts try to propose processes of risk assessment and risk...

  • Horses for courses: risk information and decision making in the regulation of nanomaterials. Beaudrie, Christian; Kandlikar, Milind // Journal of Nanoparticle Research;Apr2011, Vol. 13 Issue 4, p1477 

    Despite the widespread commercial use of nanomaterials, regulators currently have a limited ability to characterize and manage risks. There is a paucity of data available on the current production and use of nanomaterials and extreme scientific uncertainty on most aspects of the risk assessment...

  • Generic Hockey-Stick Model for Estimating Benchmark Dose and Potency: Performance Relative To BMDS and Application to Anthraquinone. Bogen, Kenneth T. // Dose-Response;2011, Vol. 9 Issue 2, p182 

    Benchmark Dose Model software (BMDS), developed by the U.S. Environmental Protection Agency, involves a growing suite of models and decision rules now widely applied to assess noncancer and cancer risk, yet its statistical performance has never been examined systematically. As typically applied,...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics